Peters, Michael H.
Article History
Received: 1 June 2022
Accepted: 16 September 2022
First Online: 28 September 2022
Competing interests
: M.H.P.’s experimental and therapeutic development COVID-19 research is partly funded by Hoth Therapeutics Inc, NY.